dr. brammer on data with inotuzumab ozogamicin in all
Published 4 years ago • 395 plays • Length 2:30Download video MP4
Download video MP3
Similar videos
-
1:15
dr. brammer on the importance of mrd in relapsed/refractory all
-
3:13
when to use inotuzumab ozogamicin for adult all
-
1:17
dr. deangelo on inotuzumab ozogamicin for relapsed/refractory all
-
3:29
is inotuzumab ozogamicin with low-dose chemotherapy effective in treating all in elderly patients?
-
2:17
choosing between inotuzumab ozogamicin and blinatumomab in patients with r/r all
-
4:44
emerging novel approaches for all: inotuzumab ozogamicin
-
3:31
relapsed/refractory all: inotuzumab ozogamicin
-
2:15
inotuzumab ozogamicin for mrd-positive b-all
-
1:13
phase ii study of inotuzumab ozogamicin in mrd b-all
-
1:01
dr. mannis on the application of gemtuzumab ozogamicin in patients with aml
-
3:12
inotuzumab ozogamicin in the treatment of patients with r/r all and extramedullary disease
-
1:20
the evolving role of inotuzumab ozogamicin in the treatment of pediatric & older patients with all
-
3:03
novel all treatment strategies: inotuzumab ozogamicin
-
0:41
dr. brammer on fda approval of brentuximab vedotin in ctcl
-
1:37
phase ii trial of inotuzumab ozogamicin to treat mrd b-all
-
1:27
what is the role of inotuzumab ozogamicin in all
-
4:44
safety and efficacy of blinatumomab and inotuzumab ozogamicin in multiple relapsed all
-
1:57
dr. advani compares inotuzumab and blinatumomab for all
-
8:44
inotuzumab ozogamicin in paediatric cd22-positive r/r acute lymphoblastic leukaemia: results of ...